The scientist’s investigation covers issues in Dementia, Alzheimer's disease, Internal medicine, Pathology and Audiology. In general Dementia study, his work on Cognitive decline often relates to the realm of Association, thereby connecting several areas of interest. Mary M. Machulda interconnects Apolipoprotein E, Psychiatry, Effects of sleep deprivation on cognitive performance and Cohort in the investigation of issues within Alzheimer's disease.
His research investigates the connection between Internal medicine and topics such as Oncology that intersect with issues in Diabetes mellitus. The various areas that he examines in his Pathology study include Biomarker, Positron emission tomography and Magnetic resonance imaging. The concepts of his Audiology study are interwoven with issues in Cognitive psychology, Atrophy, Apraxia, Free recall and Brain mapping.
His scientific interests lie mostly in Internal medicine, Dementia, Pathology, Cognition and Audiology. Mary M. Machulda works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Apolipoprotein E, as a part of the same area of interest. His Dementia research is multidisciplinary, incorporating elements of Gerontology, Cohort study, Pediatrics and Hazard ratio.
His work carried out in the field of Pathology brings together such families of science as Positron emission tomography, Magnetic resonance imaging and Neuroimaging. Mary M. Machulda has included themes like Primary progressive aphasia and Apraxia, Aphasia in his Audiology study. Mary M. Machulda has researched Alzheimer's disease in several fields, including Standardized uptake value and Amyloidosis.
His primary scientific interests are in Dementia, Cognitive decline, Internal medicine, Disease and Cognition. His work deals with themes such as Longitudinal study and Anxiety, which intersect with Dementia. His Cognitive decline study also includes fields such as
His research on Internal medicine focuses in particular on Alzheimer's disease. His study in Disease is interdisciplinary in nature, drawing from both Stage, Pediatrics and Neuropsychology. His biological study spans a wide range of topics, including Fractional anisotropy, Neurodegeneration and Amyloidosis.
Mary M. Machulda mainly focuses on Disease, Alzheimer's disease, Dementia, Internal medicine and Logopenic progressive aphasia. His research in Alzheimer's disease tackles topics such as Standardized uptake value which are related to areas like Depression, Cognitive decline, Prospective cohort study, Hazard ratio and Proportional hazards model. Dementia is the subject of his research, which falls under Pathology.
His Internal medicine research includes elements of Multiple sclerosis and Neurology. His Logopenic progressive aphasia research incorporates elements of Functional networks, Posterior cortical atrophy, Neuroimaging, Primary progressive aphasia and Atrophy. As part of one scientific family, Mary M. Machulda deals mainly with the area of Apolipoprotein E, narrowing it down to issues related to the Amyloid β, and often Pittsburgh compound B.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients
M. M. Machulda;H. A. Ward;B. Borowski;J. L. Gunter.
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack;Heather J. Wiste;Stephen D. Weigand;Terry M. Therneau.
Alzheimers & Dementia (2017)
Assessing the Temporal Relationship Between Cognition and Gait: Slow Gait Predicts Cognitive Decline in the Mayo Clinic Study of Aging
Michelle M. Mielke;Rosebud O. Roberts;Rodolfo Savica;Ruth Cha.
Journals of Gerontology Series A-biological Sciences and Medical Sciences (2013)
Non-Stationarity in the ``Resting Brain's'' Modular Architecture
David T. Jones;Prashanthi Vemuri;Matthew C. Murphy;Jeffrey L. Gunter.
PLOS ONE (2012)
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
Bradley F. Boeve;Kevin B. Boylan;Neill R. Graff-Radford;Mariely DeJesus-Hernandez.
Age-related changes in the default mode network are more advanced in Alzheimer disease
D.T. Jones;M.M. Machulda;P. Vemuri;E.M. McDade.
Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech
Keith Anthony Josephs;Joseph R Duffy;Edythe Strand;Mary Margaret Machulda.
Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span
Clifford R. Jack;Heather J. Wiste;Stephen D. Weigand;David S. Knopman.
JAMA Neurology (2015)
Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
Michelle M. Mielke;Clinton E. Hagen;Jing Xu;Xiyun Chai.
Alzheimers & Dementia (2018)
Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia
Rosebud O Roberts;Teresa J H Christianson;Walter K Kremers;Michelle M Mielke.
JAMA Neurology (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: